Dr. Hönle AG (FRA:HNL)

Dr. Hönle AG Statistics

Total Valuation

Dr. Hönle AG has a market cap or net worth of EUR 51.53 million. The enterprise value is 96.54 million.

Market Cap	51.53M
Enterprise Value	96.54M

Important Dates

The last earnings date was Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	6.06M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	4.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	48.49
PS Ratio	0.53
PB Ratio	0.66
P/TBV Ratio	0.79
P/FCF Ratio	17.43
P/OCF Ratio	10.51
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.01, with an EV/FCF ratio of 32.66.

EV / Earnings	-7.10
EV / Sales	1.00
EV / EBITDA	20.01
EV / EBIT	n/a
EV / FCF	32.66

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.65.

Current Ratio	1.79
Quick Ratio	0.71
Debt / Equity	0.65
Debt / EBITDA	10.52
Debt / FCF	17.18
Interest Coverage	-0.27

Financial Efficiency

Return on equity (ROE) is -15.57% and return on invested capital (ROIC) is -0.24%.

Return on Equity (ROE)	-15.57%
Return on Assets (ROA)	-0.21%
Return on Invested Capital (ROIC)	-0.24%
Return on Capital Employed (ROCE)	-0.45%
Revenue Per Employee	173,283
Profits Per Employee	-24,360
Employee Count	590
Asset Turnover	0.61
Inventory Turnover	1.15

Taxes

In the past 12 months, Dr. Hönle AG has paid 765,000 in taxes.

Income Tax	765,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.68% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-50.68%
50-Day Moving Average	9.46
200-Day Moving Average	9.06
Relative Strength Index (RSI)	31.84
Average Volume (20 Days)	4,767

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dr. Hönle AG had revenue of EUR 96.69 million and -13.59 million in losses. Loss per share was -2.24.

Revenue	96.69M
Gross Profit	59.62M
Operating Income	-538,000
Pretax Income	-12.61M
Net Income	-13.59M
EBITDA	3.51M
EBIT	-538,000
Loss Per Share	-2.24

Balance Sheet

The company has 5.91 million in cash and 50.80 million in debt, giving a net cash position of -44.89 million.

Cash & Cash Equivalents	5.91M
Total Debt	50.80M
Net Cash	-44.89M
Net Cash Per Share	n/a
Equity (Book Value)	78.25M
Book Value Per Share	12.89
Working Capital	24.13M

Cash Flow

In the last 12 months, operating cash flow was 4.90 million and capital expenditures -1.95 million, giving a free cash flow of 2.96 million.

Operating Cash Flow	4.90M
Capital Expenditures	-1.95M
Free Cash Flow	2.96M
FCF Per Share	n/a

Margins

Gross margin is 61.66%, with operating and profit margins of -0.56% and -14.06%.

Gross Margin	61.66%
Operating Margin	-0.56%
Pretax Margin	-13.04%
Profit Margin	-14.06%
EBITDA Margin	3.63%
EBIT Margin	-0.56%
FCF Margin	3.06%

Dividends & Yields

Dr. Hönle AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-26.38%
FCF Yield	5.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Dr. Hönle AG has an Altman Z-Score of 1.67 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.67
Piotroski F-Score	4